MAZEN HARIRI: Open Payments
NPI 1740628213 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 11 companies in 2025. Trend: 2023 $458 · 2024 $575 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Abbott Laboratories | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: FREESTYLE LIBRE 3, TZIELD, AIRSUPRA, MOUNJARO, Ozempic, PAXLOVID, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
